FDA Recall - ETHEX Recalls ADDITIONAL Lots of Extended Release Morphine Sulfate 30mg and 60mg

ETHEX Corporation announced today that it has voluntarily recalled specific additional morphine sulfate 60 mg extended release tablets, and specific lots of morphine sulfate 30 mg extended release tablets, as a precaution, due to the possible presence of oversized tablets. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The recalled lots were distributed by ETHEX Corporation under an "ETHEX" label between June 2006 and May 2008.

The 30 mg extended release tablets are pink oval tablets with "30" on one side, and "E" on reverse the 60 mg extended release tablets are white oval tablets with "60" on one side, and "E" on the reverse.

This FDA expanded recall can be found HERE.

FDA Recall - Morphine Sulfate 60 mg Extended Release Tablets

ETHEX Corporation announced today that it has voluntarily recalled a single lot of morphine sulfate 60 mg extended release tablets (Lot No. 91762) due to a report of a tablet with twice the appropriate thickness. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The lot was distributed by ETHEX Corporation under an "ETHEX" label between April 16th and April 27th of 2008. No other dosage strength, nor any other lot of the 60 mg strength is affected by this recall.

The entire FDA recall can be found HERE.